304 related articles for article (PubMed ID: 7629518)
1. The protein product of the c-cbl protooncogene is phosphorylated after B cell receptor stimulation and binds the SH3 domain of Bruton's tyrosine kinase.
Cory GO; Lovering RC; Hinshelwood S; MacCarthy-Morrogh L; Levinsky RJ; Kinnon C
J Exp Med; 1995 Aug; 182(2):611-5. PubMed ID: 7629518
[TBL] [Abstract][Full Text] [Related]
2. SH3 domain of Bruton's tyrosine kinase can bind to proline-rich peptides of TH domain of the kinase and p120cbl.
Patel HV; Tzeng SR; Liao CY; Chen SH; Cheng JW
Proteins; 1997 Dec; 29(4):545-52. PubMed ID: 9408950
[TBL] [Abstract][Full Text] [Related]
3. Solution structure of the human BTK SH3 domain complexed with a proline-rich peptide from p120cbl.
Tzeng SR; Lou YC; Pai MT; Jain ML; Cheng JW
J Biomol NMR; 2000 Apr; 16(4):303-12. PubMed ID: 10826882
[TBL] [Abstract][Full Text] [Related]
4. The SH3 domain of Bruton's tyrosine kinase interacts with Vav, Sam68 and EWS.
Guinamard R; Fougereau M; Seckinger P
Scand J Immunol; 1997 Jun; 45(6):587-95. PubMed ID: 9201297
[TBL] [Abstract][Full Text] [Related]
5. Bruton's tyrosine kinase activity is negatively regulated by Sab, the Btk-SH3 domain-binding protein.
Yamadori T; Baba Y; Matsushita M; Hashimoto S; Kurosaki M; Kurosaki T; Kishimoto T; Tsukada S
Proc Natl Acad Sci U S A; 1999 May; 96(11):6341-6. PubMed ID: 10339589
[TBL] [Abstract][Full Text] [Related]
6. The SH3 domain of Bruton's tyrosine kinase displays altered ligand binding properties when auto-phosphorylated in vitro.
Morrogh LM; Hinshelwood S; Costello P; Cory GO; Kinnon C
Eur J Immunol; 1999 Jul; 29(7):2269-79. PubMed ID: 10427990
[TBL] [Abstract][Full Text] [Related]
7. Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA).
Zhu Q; Zhang M; Rawlings DJ; Vihinen M; Hagemann T; Saffran DC; Kwan SP; Nilsson L; Smith CI; Witte ON; Chen SH; Ochs HD
J Exp Med; 1994 Aug; 180(2):461-70. PubMed ID: 7519238
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of two regulatory tyrosine residues in the activation of Bruton's tyrosine kinase via alternative receptors.
Wahl MI; Fluckiger AC; Kato RM; Park H; Witte ON; Rawlings DJ
Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11526-33. PubMed ID: 9326643
[TBL] [Abstract][Full Text] [Related]
9. An SH3-binding site conserved in Bruton's tyrosine kinase and related tyrosine kinases mediates specific protein interactions in vitro and in vivo.
Yang W; Malek SN; Desiderio S
J Biol Chem; 1995 Sep; 270(35):20832-40. PubMed ID: 7657668
[TBL] [Abstract][Full Text] [Related]
10. BAP-135, a target for Bruton's tyrosine kinase in response to B cell receptor engagement.
Yang W; Desiderio S
Proc Natl Acad Sci U S A; 1997 Jan; 94(2):604-9. PubMed ID: 9012831
[TBL] [Abstract][Full Text] [Related]
11. Cbl-b positively regulates Btk-mediated activation of phospholipase C-gamma2 in B cells.
Yasuda T; Tezuka T; Maeda A; Inazu T; Yamanashi Y; Gu H; Kurosaki T; Yamamoto T
J Exp Med; 2002 Jul; 196(1):51-63. PubMed ID: 12093870
[TBL] [Abstract][Full Text] [Related]
12. Binding of Bruton's tyrosine kinase to Fyn, Lyn, or Hck through a Src homology 3 domain-mediated interaction.
Cheng G; Ye ZS; Baltimore D
Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8152-5. PubMed ID: 8058772
[TBL] [Abstract][Full Text] [Related]
13. The protein product of the c-cbl oncogene rapidly complexes with the EGF receptor and is tyrosine phosphorylated following EGF stimulation.
Bowtell DD; Langdon WY
Oncogene; 1995 Oct; 11(8):1561-7. PubMed ID: 7478580
[TBL] [Abstract][Full Text] [Related]
14. The protein product of the c-cbl protooncogene is the 120-kDa tyrosine-phosphorylated protein in Jurkat cells activated via the T cell antigen receptor.
Donovan JA; Wange RL; Langdon WY; Samelson LE
J Biol Chem; 1994 Sep; 269(37):22921-4. PubMed ID: 8083187
[TBL] [Abstract][Full Text] [Related]
15. Cbl-b negatively regulates B cell antigen receptor signaling in mature B cells through ubiquitination of the tyrosine kinase Syk.
Sohn HW; Gu H; Pierce SK
J Exp Med; 2003 Jun; 197(11):1511-24. PubMed ID: 12771181
[TBL] [Abstract][Full Text] [Related]
16. IL-5 receptor-mediated tyrosine phosphorylation of SH2/SH3-containing proteins and activation of Bruton's tyrosine and Janus 2 kinases.
Sato S; Katagiri T; Takaki S; Kikuchi Y; Hitoshi Y; Yonehara S; Tsukada S; Kitamura D; Watanabe T; Witte O; Takatsu K
J Exp Med; 1994 Dec; 180(6):2101-11. PubMed ID: 7525847
[TBL] [Abstract][Full Text] [Related]
17. Transcription factor STAT5A is a substrate of Bruton's tyrosine kinase in B cells.
Mahajan S; Vassilev A; Sun N; Ozer Z; Mao C; Uckun FM
J Biol Chem; 2001 Aug; 276(33):31216-28. PubMed ID: 11413148
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of Bruton's tyrosine kinase by c-Abl.
Bäckesjö CM; Vargas L; Superti-Furga G; Smith CI
Biochem Biophys Res Commun; 2002 Dec; 299(3):510-5. PubMed ID: 12445832
[TBL] [Abstract][Full Text] [Related]
19. Bruton's tyrosine kinase is required for activation of IkappaB kinase and nuclear factor kappaB in response to B cell receptor engagement.
Petro JB; Rahman SM; Ballard DW; Khan WN
J Exp Med; 2000 May; 191(10):1745-54. PubMed ID: 10811867
[TBL] [Abstract][Full Text] [Related]
20. The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3' kinase pathway.
Sattler M; Salgia R; Okuda K; Uemura N; Durstin MA; Pisick E; Xu G; Li JL; Prasad KV; Griffin JD
Oncogene; 1996 Feb; 12(4):839-46. PubMed ID: 8632906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
